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It was hypothesized that isoflavones may attenuate ergot alkaloid-induced vasoconstriction and possibly alleviate diminished contractility of vasculature after exposure to ergot
alkaloids. The objective of this study was to determine if prior incubation of bovine mesenteric vasculature with the isoflavones formononetin (F), biochanin A (B), or an ergovaline-containing tall fescue seed extract (EXT) and their combinations affect ergotamine
(ERT)-induced contractility. Multiple segments of mesenteric artery and vein supporting
the ileal flange of the small intestine were collected from Angus heifers at slaughter (n = 5,
bodyweight = 639 ± 39 kg). Duplicates of each vessel type were incubated in tissue culture flasks at 37°C with a 50-mL volume of Krebs–Henseleit buffer containing: only buffer
(control); or 1 × 10−6 M EXT; F; or B; and combinations of 1 × 10−6 M EXT + F; 1 × 10−6 M
EXT + B; 1 × 10−6 M F + B; or 1 × 10−6 M EXT + F + B. After incubation for 2 h, sections
were mounted in a multimyograph chamber. The ERT dose responses were normalized
to 0.12 M KCl. Pretreatment with F, B, and F + B without EXT resulted in similar contractile responses to ERT in mesenteric artery and all incubations containing EXT resulted in a
complete loss of vasoactivity to ERT. In mesenteric artery pretreated with EXT, treatments
that contained B had higher contractile responses (P < 0.05) at ERT concentrations of
1 × 10−7 and 5 × 10−7 M. Also, treatments containing B tended (P < 0.1) to have greater
responses than treatments without B at ERT concentrations of 1 × 10−6, 5 × 10−6, and
5 × 10−5 M. In mesenteric vein pretreated with EXT, treatments containing F had greater
contractile responses to ERT at 1 × 10−5, 5 × 10−5, and 1 × 10−4 M (P < 0.05). These
data indicated that F and B at 1 × 10−6 M and their combination did not impact the overall
contractile response to ERT in mesenteric vasculature. However, F and B may offset
some of the vasoconstriction caused by prior exposure to ergot alkaloids.
Keywords: ergot alkaloids, isoflavones, mesenteric vasculature, vasoconstriction

INTRODUCTION
As a symbiotic endophyte of tall fescue (Lolium arundinaceum) (1–4), Epichloë coenophiala
produces a variety of ergot alkaloids (5, 6), which have been identified as causative agents of
vasoconstriction and symptoms of fescue toxicosis in grazing animals (7, 8). Ergovaline and
ergotamine commonly draw more attention of researchers. Lyons et al. (5) reported that ergovaline
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was the predominant (84–97%) alkaloid of all the five detected
ergopeptine alkaloids from tall fescue (Lolium arundinaceum)
pasture. Numerous studies have reported that ergot alkaloids
(ergovaline and ergotamine) induce vasoconstriction in
peripheral blood vessel models such as the caudal artery (9,
10), dorsal pedal vein (11), and lateral saphenous vein (12),
and also core blood vessel models like the right ruminal artery
and vein (13), bovine uterine and umbilical arteries (14), and
mesenteric artery and vein (15). Consistent with findings in
the bovine lateral saphenous vein (16, 17), Egert et al. (15)
demonstrated that previous dietary exposure to ergot alkaloids
reduced the vasoactivity in bovine mesenteric vasculature.
Isoflavones are almost exclusively found in the legume
(Leguminosae/Fabaceae) family, such as soybean, chickpeas, and
red clover (18, 19). A variety of isoflavones, such as genistein,
daidzein, biochanin A (B), and formononetin (F), have been
shown to elicit different beneficial effects on humans in many
different ways, for example, improvements to the cardiovascular
system, osteoporosis, anti-breast, and prostate cancer (20–23).
Substantial evidence has been published on the vasodilative
effects of isoflavones and their metabolites in different vessel
types in humans (24, 25) and rats (26–29). However, based on our
knowledge, no studies have investigated the vasodilative effects of
isoflavones on bovine vessels.
Ergot alkaloids share some structural similarities with
biogenic amines (i.e., dopamine, epinephrine, norepinephrine,
serotonin) and thus can cause vasoconstriction by binding
biogenic amine receptors (30) found throughout the body. On
the other hand, isoflavones have estrogenic activities and could
cause endothelium-dependent or -independent vasorelaxation.
Although the precise mechanisms behind the vascular bioactivity
of both ergot alkaloids and isoflavones have not been fully defined,
current knowledge suggests that they are triggered by different
mechanisms. Nevala et al. (31) reported that isoflavones relax
noradrenaline precontracted rat mesenteric arteries. Likewise,
Egert et al. (15) demonstrated that ergot alkaloids were vasoconstrictive in bovine mesenteric vasculature, whereas dietary
exposure to ergot alkaloids decreased the contractility of mesenteric vasculature. Thus, it was hypothesized that isoflavones may
attenuate ergot alkaloid-induced vasoconstriction and possibly
alleviate the diminished contractility of mesenteric vasculature
after preliminary exposure to ergot alkaloids. The objective of
this study was to determine if an incubation of bovine mesenteric
vasculature with F, B, or ergovaline-containing tall fescue seed
extract (EXT) and their combinations affect ergotamine (ERT)induced contractility.

gastrointestinal tract was removed from the carcass, and the
cecum, ileocecal fold, and the ileal flange were identified as
landmarks. Within the mesentery supporting the ileal flange,
multiple branches of the mesenteric artery and vein bundles
were dissected and submerged in oxygenated Krebs–Henseleit
buffer (95% O2/5% CO2; pH = 7.4; 11.1 mM d-glucose; 1.2 mM
MgSO4; 1.2 mM KH2PO4; 4.7 mM KCl; 118.1 mM NaCl; 3.4 mM
CaCl2; 24.9 mM NaHCO3; Sigma Chemical Co., St. Louis, MO,
USA) for transport to the laboratory. Samples were stored on
ice until cleaned. At the time of cleaning, surrounding fat and
connective tissues were carefully removed, and mesentery artery
and vein were separated under a magnifying lamp (2.5 to 5.0×
magnification). Cleaned vessels were sliced into 2-mm segments
and examined under a dissecting scope (Semi 2000-C, Carl Zeiss
Inc., Oberkochen, Germany) at 12.5× magnification to ensure
the usability of the vessels. Cross-sections with abnormalities
(branches, valves, or structural damage) were replaced with
structurally integral ones.

Pre-Myograph Incubations

A tall fescue seed extract was prepared as described by Foote et al.
(33) to contain a 1 × 10−6 M working concentration of ergovaline.
Duplicates of each vessel type (from each animal) were incubated
in tissue culture flasks with a 50-mL volume of Krebs–Henseleit
buffer containing: only buffer (control); 1 × 10−6 M EXT;
1 × 10−6 M F (≥99.0%; 47752-5MG-F; Sigma Chemical Co., St.
Louis, MO, USA); or 1 × 10−6 M B (D2016; Sigma Chemical Co.,
St. Louis, MO, USA); and combinations of 1 × 10−6 M EXT + F;
1 × 10−6 M EXT + B; 1 × 10−6 M F + B; or 1 × 10−6 M EXT + F + B.
All buffer solutions were prewarmed for 30 min in a CO2 incubator (95% O2/5% CO2; 37°C; Nu-8500, NUAIRE, Inc., Plymouth,
MN, USA) prior to blood vessel addition. Duplicate blood vessel
segments were randomly placed into each treatment flask and
incubated in the same conditions for 2 h. Immediately after the
2-h incubation, dimensional measurements of cross-sections
were recorded only for mesentery artery using Axiovision (version 20, Carl Zeiss, Inc.).

Experimental Myograph Protocol

Following the 2-h incubations, an ERT concentration response
experiment was conducted using the procedures described by
Klotz and Barnes (32). ERT (ergotamine d-tartrate; 97%; 45510;
Aldrich, Milwaukee, WI, USA) standards were prepared by
diluting a stock solution (0.0201 M) with dimethyl sulfoxide to
working concentrations that resulted in a concentration range of
5 × 10−9 to 1 × 10−4 M in the myograph chamber (contained 5 mL
of Krebs–Henseleit buffer).
Artery and vein cross-sections were mounted on the myograph (Multichamber myograph; DMT 610M, Danish Myo
Technology, Atlanta, GA, USA) by inserting the supports through
the lumen in individual myograph chambers containing 5 mL
modified Krebs–Henseleit buffer and continuously gassed (95%
O2/5% CO2; pH = 7.4; 37°C). The incubation buffer was modified
from transport Krebs–Henseleit buffer by adding desipramine
(3 × 10−5 M; D3900; Sigma Chemical Co.) to inhibit the reuptake
mechanisms of biogenic amines and propranolol (1 × 10−6 M;
P0844; Sigma Chemical Co.) to block the non-specific binding

MATERIALS AND METHODS
No live animals were involved this study, so approval from the
University of Kentucky Animal Care and Use Committee was not
required.

Animals and Tissue Collection

Five Angus heifers (Bodyweight = 639 ± 39 kg) were slaughtered and tissues were collected at the University of Kentucky
abattoir. As originally described by Klotz and Barnes (32), the
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of ERT to β-adrenergic receptors. A 90-min equilibration period
with buffer replacement occurring every 15 min was completed
based on the conditions above to achieve a stable resting tension
of approximately 1 g. Following the equilibration period, the
blood vessels were exposed to 120 mM KCl for 15 min to evaluate
tissue viability and to normalize treatment data. Following the
KCl addition, the incubation buffer was replaced every 15 min
until vessel tension returned to the 1 g baseline. Once the vessel
returned to baseline, addition of ERT standards was initiated in
order to increase the concentration. ERT additions were added
in 15-min intervals consisting of a 9-min-incubation period, two
2.5-min buffer washes, and a third, final buffer replacement that
was followed by 1-min recovery before the next ERT addition.
This 15 min cycle was repeated for the rest of the nine remaining
ERT additions. Following the 1-min recovery after the final ERT
addition, vessels were again exposed to 120 mM KCl to confirm
the vessel viability at the end of the experiment.

be obtained for mesenteric vein samples due to the pliable nature
of this vessel) were analyzed as a completely randomized design
with a factorial treatment arrangement. The fixed effects included
the effects of F, B, and the interaction of F × B in the presence or
absence of EXT. Due to the shape of the response curve, EC50 data
were analyzed only in treatments without EXT from mesentery
artery using a completely randomized design with treatment as
fixed variable. For all data, pair-wise comparisons of least square
means (±SEM) were only performed if the probability of a greater
F-statistic from the analysis of variance was significant for the
tested effect and interaction. Mean separation was performed
with the LSD feature of SAS. Differences are denoted as significant
at P < 0.05, unless specifically reported otherwise.

RESULTS
The F and B incubation pretreatment did not impact (P > 0.05)
the maximum contractile response of mesenteric artery or
mesenteric vein to 120 mM KCl either without EXT (Table 1)
or with EXT (Table 2). The pretreatments with EXT did not
compromise the vessel viability, which was indicated by the ending response to KCl for either the artery or vein (Figure 1). In
mesenteric artery, the inside and outside diameters after the 2 h
incubation were not affected (P > 0.05) by F or B in both treatment groups with (Table 2) or without EXT (Table 1). However,
there was a tendency (P = 0.07) for F treated vessels to have a
larger inside diameter for those pretreated with EXT (Table 2),
and a smaller outside diameter (P = 0.09) for those not pretreated
with EXT (Table 1). Interestingly, mesenteric artery pretreated
with B tended (P = 0.06) to have a smaller inside diameter when
incubated with EXT (Table 2).
In the mesenteric artery, ERT induced similar contractile
responses in all treatments (Figure 2) with −logEC50 values
(5.99 ± 0.14, 5.80 ± 0.14, 5.88 ± 0.14, 5.74 ± 0.14 M, respectively) that did not differ with each other (P = 0.63). Within
each ERT concentration, tendencies for F × B interactions in
mesenteric artery were observed at ERT 5 × 10−9, 1 × 10−8,
5 × 10−8 M (P = 0.09, P = 0.07, P = 0.08, respectively; Table 3) for
treatments without EXT. Contractile responses of F + B treated
mesentery artery were greater than B at ERT concentrations
1 × 10−8 and 5 × 10−8 M (P < 0.05). In mesenteric vein, ERTinduced contractile responses reached the maximum response
at 1 × 10−6 M for Control, B, F, F + B treatments (Figure 3), and
then relaxed to negative response values with increases in ERT
concentration.
For the blood vessels incubated with EXT, the contractile
responses decreased as the concentration of ERT increased in
both mesenteric artery (Figure 4) and mesenteric vein (Figure 5).
In mesenteric artery, a main effect of B was observed at ERT concentrations of 1 × 10−7 and 5 × 10−7 M (Table 4), with treatments
that contained B having higher contractile responses (P < 0.05).
Also, treatments containing B tended (P < 0.1) to have greater
responses than treatments without B at ERT concentrations of
1 × 10−6, 5 × 10−6, and 5 × 10−5 M (Table 4).
In the mesenteric vein, the contractile response of all treatments with EXT to ERT decreased and remained below zero
from the second ERT addition (1 × 10−8 M) to the last addition at

Data Collection

The isometric contractions of the different preincubated mesenteric vessels to KCl and ERT additions were digitized and
recorded as grams of tension using a PowerLab/8sp and Chart
software (version 7.3, ADInstruments, Colorado Springs, Co.).
Baseline tension was measured immediately before the addition
of 120 mM KCl. For all contractile response data, the maximum
observed tension (in grams) in the 9 min-incubation period was
recorded as the contractile response. Contractile response data
were corrected for baseline tension and normalized as a percentage of the reference compound KCl induced maximum contractile
response. The differences of tissue response due to the variations
of vessel size and across individual animal were minimized by
this data normalization. The contractile response to ERT was
determined and presented as percentage means ± SEM. A measurement of potency or the half-maximal effective concentration
(EC50) was calculated using GraphPad Prism (version 5; GraphPad
Software Inc., La Jolla, CA, USA) using a non-linear regression
with fixed slope. The sigmoidal concentration response curves of
pretreated mesentery artery and vein to ERT was plotted by using
a three-parameter equation:


top-bottom 
y = bottom + 
,
 1 + 10( log EC50 − x )  


where y represents contractile response, and x denotes the agonist
concentration, top and bottom are the plateaus of contractile
response as percentage of 120 mM KCl maximum response. The
EC50 is the molar concentration of ERT inducing 50% of the KCl
maximum response.

Statistics

All data were analyzed using the MIXED model of SAS (SAS 9.4,
SAS Inst. Inc., Cary, NC, USA). Contractile response data of mesentery artery and vein were analyzed separately as two datasets for
treatments with and without EXT. Data for contractile response
(within each ERT concentration), KCl maximal response, inside
and outside diameters for mesenteric artery (these data could not
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TABLE 1 | Inside diameter, outside diameter, and SEM of mesenteric artery, and the mean KCl maximum response of mesenteric artery and vein
to pretreatment without tall fescue extract: only Krebs–Henseleit buffer (control); 1 × 10−6 M treatments of formononetin (F), biochanin A (B), and
combination of F and B (F + B).
Item

Control

F

F+B

B

SEM

P-value
F

B

F×B

Mesenteric artery
KCl maximum response (g)
Inside diameter (mm)
Outside diameter (mm)

4.36
0.81
1.72

4.42
0.79
1.64

4.22
0.86
1.75

3.66
0.77
1.57

0.46
0.06
0.07

0.58
0.38
0.09

0.33
0.77
0.74

0.50
0.61
0.47

Mesenteric veina
KCl maximum response (g)

1.70

1.81

1.89

2.22

0.21

0.31

0.18

0.62

Due to the elasticity of the mesenteric vein, measurements of vascular dimensions were not possible.

a

TABLE 2 | Inside diameter, outside diameter, and SEM of mesenteric artery, and the mean KCl maximum response of mesenteric artery and vein
to pretreatment with tall fescue seed extract: 1 × 10−6 M ergovaline-containing tall fescue seed extract (EXT); combinations of 1 × 10−6 M EXT and
formononetin (F), EXT and biochanin A (B), and the combination of EXT + F + B.
Item

EXT

EXT + F

EXT + B

EXT + F + B

SEM

P-value
F

B

F×B

Mesenteric artery
KCl maximum response (g)
Inside diameter (mm)
Outside diameter (mm)

3.43
0.72
1.64

2.68
0.78
1.57

3.08
0.60
1.51

2.84
0.72
1.59

0.37
0.05
0.07

0.19
0.07
0.92

0.80
0.06
0.43

0.50
0.50
0.29

Mesenteric veina
KCl maximum response (g)

1.90

2.20

2.09

2.49

0.21

0.11

0.26

0.81

a

Due to the elasticity of the mesenteric vein, measurements of vascular dimensions were not possible.

FIGURE 1 | Example of a typical response of mesenteric artery (A) and vein (B) cross-sections, after pretreated with 1 × 10−6 M EXT and 1 × 10−6 M F
and 1 × 10−6 M B (EXT + F + B), to increasing concentrations of ERT (5 × 10−9 to 1 × 10−4 M). The rectangles highlighted regions are the initial and end KCl
(0.12 M) additions.
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FIGURE 2 | Mean contractile response, as % KCl maximum of
mesenteric artery to increasing concentrations of ergotamine for
pretreatments without tall fescue seed extract: only Krebs–Henseleit
buffer (control); 1 × 10−6 M formononetin (F); or 1 × 10−6 M biochanin A
(B); and combination of 1 × 10−6 M F and 1 × 10−6 M B (F + B). The
regression lines were plotted for each treatment using a non-linear regression
with fixed slope, and the sigmoidal concentration response curves were
calculated by the following equation: y = bottom + (top-bottom)/(1 + 10(log EC50 − x ) )  ,
where top and bottom are the plateaus of contractile response as percentage of
120 mM KCl maximum response. EC50 is the molar concentration of ergotamine
inducing 50% of the KCl maximum response.

FIGURE 3 | Mean contractile response, as % KCl maximum of
mesenteric vein to increasing concentrations of ergotamine for
pretreatments without tall fescue seed extract: only Krebs–
Henseleit buffer (control); 1 × 10−6 M formononetin (F); or
1 × 10−6 M biochanin A (B); and combination of 1 × 10−6 M F and
1 × 10−6 M B (F + B). The regression lines were plotted for each
treatment using a non-linear regression with fixed slope, and the sigmoidal
concentration response curves were calculated by the following equation:
y = bottom + (top-bottom)/(1 + 10(log EC50 − x ) )  ,where top and bottom are the
plateaus of contractile response as percentage of 120 mM KCl maximum
response. EC50 is the molar concentration of ergotamine inducing 50% of the
KCl maximum response.

TABLE 3 | The analysis of variance and P-values of main effect of
formononetin (F), biochanin A (B), and the interaction of formononetin
and biochanin A (F × B) for pretreatments without tall fescue extract:
only Krebs–Henseleit buffer; 1 × 10−6 M F, B, and combination of F and B
on every ergotamine concentration.
Ergotamine concentration (M)

P-value
F

B

F×B

Mesenteric artery
5 × 10−9
1 × 10−8
5 × 10−8
1 × 10−7
5 × 10−7
1 × 10−6
5 × 10−6
1 × 10−5
5 × 10−5
1 × 10−4

0.23
0.14
0.20
0.29
0.88
0.68
0.27
0.38
0.43
0.61

0.91
0.27
0.51
0.83
0.79
0.78
0.99
0.97
0.81
0.54

0.09
0.07
0.08
0.31
0.43
0.64
0.72
0.97
0.77
0.59

Mesenteric vein
5 × 10−9
1 × 10−8
5 × 10−8
1 × 10−7
5 × 10−7
1 × 10−6
5 × 10−6
1 × 10−5
5 × 10−5
1 × 10−4

0.92
1.00
0.67
0.80
0.99
0.93
0.78
0.50
0.29
0.23

0.27
0.96
0.67
0.64
0.43
0.30
0.43
0.80
0.93
0.86

0.85
0.50
0.28
0.41
0.74
0.70
0.70
0.62
0.61
0.89

FIGURE 4 | Mean contractile response, as % KCl maximum of
mesenteric artery to increasing concentrations of ergotamine for
pretreatments with tall fescue seed extract: 1 × 10−6 M ergovalinecontaining tall fescue seed extract (EXT); combinations of
1 × 10−6 M EXT and 1 × 10−6 M F (EXT + F); 1 × 10−6 M EXT and
1 × 10−6 M B (EXT + B); or 1 × 10−6 M EXT and 1 × 10−6 M F and
1 × 10−6 M B (EXT + F + B). The regression lines were plotted for each
treatment using a non-linear regression with fixed slope, and the sigmoidal
concentration response curves were calculated by the following equation:
y = bottom + (top-bottom)/(1 + 10(log EC50 − x ) )  , where top and bottom are the
plateaus of contractile response as percentage of 120 mM KCl maximum
response. EC50 is the molar concentration of ergotamine inducing 50% of
the KCl maximum response.

1 × 10−4 M. Tendencies for main effects of B (P = 0.06) and F × B
interaction (P = 0.09) were observed at ERT concentrations of
5 × 10−9 M, where EXT treatment had a lower contractile response
than EXT + B (P < 0.05; Table 4). Treatments containing F had
Frontiers in Nutrition | www.frontiersin.org

greater contractile responses to ERT at 1 × 10−5, 5 × 10−5, and
1 × 10−4 M in mesenteric vein (main effect of F; P < 0.05; Table 4).
Within the 5 × 10−5 M ERT concentration, the contractile response
of EXT was the lowest (P = 0.03).
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TABLE 4 | The analysis of variance and P-values of main effect of
formononetin (F), biochanin A (B), and the interaction of formononetin
and biochanin A (F × B) for pretreatments with tall fescue seed extract
(EXT): 1 × 10−6 M (EXT); combinations of 1 × 10−6 M EXT and F, EXT and
B, or 1 × 10−6 M EXT + B + F on every ergotamine concentration.
Ergotamine concentration (M)

FIGURE 5 | Mean contractile response, as % KCl maximum of
mesenteric vein to increasing concentrations of ergotamine for
pretreatments with tall fescue seed extract: 1 × 10−6 M ergovalinecontaining tall fescue seed extract (EXT); combinations of
1 × 10−6 M EXT and 1 × 10−6 M F (EXT + F); 1 × 10−6 M EXT and
1 × 10−6 M B (EXT + B); or 1 × 10−6 M EXT and 1 × 10−6 M F and
1 × 10−6 M B (EXT + F + B). The regression lines were plotted for each
treatment using a non-linear regression with fixed slope, and the sigmoidal
concentration response curves were calculated by the following equation:
y = bottom + (top-bottom)/(1 + 10(log EC50 − x ) )  ,where top and bottom are the
plateaus of contractile response as percentage of 120 mM KCl maximum
response. EC50 is the molar concentration of ergotamine inducing 50% of
the KCl maximum response.

DISCUSSION
This is the first study to investigate the interaction of ergot alkaloids
and isoflavones on bovine mesenteric vasculature. Physiological
effects of isoflavones and their metabolites on vasculature have
been extensively studied on different vessel types in humans (24,
25) and rat models (26–29). The concentrations of isoflavones
(1 × 10−6 M formononetin and biochanin A) used in the current
experiment were based on a study that reported dose-dependent
formononetin- and biochanin A-induced relaxations of ratisolated thoracic aorta precontracted with phenylephrine (29).
At 1 × 10−6 M, formononetin and biochanin A were capable of
inducing about 35 and 25% relaxation, respectively. Since the current study was the first to investigate interactions of isoflavones
and ergot alkaloids, our rationale was to pick an intermediate
concentration (1 × 10−6 M) to avoid extreme scenarios and one
that was equimolar with the concentration of ergovaline. The
concentration of ergovaline-containing tall fescue seed extract
that was chosen (1 × 10−6 M) is based on the findings of Egert
et al. (15), where 1 × 10−6 M of ergovaline-containing extract
was observed to induce contractile response (about 40% of KCl
maximum) of bovine mesenteric artery and vein.
Several studies have demonstrated that cattle grazing endophyte-infected tall fescue had reduced contractile responses to
5-hydroxytryptamine (5-HT) and as well as ergot alkaloids in the
lateral saphenous vein (16, 17). Recently, a study using mesenteric
artery and vein from steers that had been ruminally dosed with
endophyte-infected tall fescue seed observed a decreased or completely absent constrictive response to ergot alkaloids (15). In the
current study, an in vitro incubation of bovine mesenteric vasculature in a medium containing EXT was used to achieve an ergot
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P-value
F

B

F×B

Mesenteric artery
5 × 10−9
1 × 10−8
5 × 10−8
1 × 10−7
5 × 10−7
1 × 10−6
5 × 10−6
1 × 10−5
5 × 10−5
1 × 10−4

0.94
0.43
0.22
0.20
0.25
0.21
0.21
0.31
0.24
0.18

0.71
0.31
0.11
0.04
0.03
0.06
0.09
0.13
0.10
0.12

0.70
0.96
0.77
0.73
0.57
0.58
0.52
0.70
0.87
0.77

Mesenteric vein
5 × 10−9
1 × 10−8
5 × 10−8
1 × 10−7
5 × 10−7
1 × 10−6
5 × 10−6
1 × 10−5
5 × 10−5
1 × 10−4

0.75
0.91
0.45
0.18
0.15
0.19
0.16
0.03
0.02
0.01

0.07
0.77
0.98
0.85
0.48
0.58
0.44
0.30
0.17
0.24

0.10
0.41
0.50
0.32
0.19
0.32
0.27
0.12
0.08
0.14

alkaloid pretreatment. The pretreatment of blood vessels with
EXT (33) and isoflavones (F and B) were conducted at equimolar
final concentrations of 1 × 10−6 M. It has been reported that F and
B both induced vasorelaxation in phenylephrine-precontracted
rat-isolated thoracic aorta at 1 × 10−6 M (29). This latter study
identified both nitric oxide from endothelial nitric oxide synthase
(NOS) and potassium efflux from endothelial cells as putative
mechanisms of action. However, the 1 × 10−6 M ergovaline in the
EXT may be considered a high dose compared to the physiological levels encountered by cattle grazing endophyte-infected tall
fescue (34). Nevertheless, the viability of mesenteric artery and
vein was not compromised by concentration of ergot alkaloids
used in the current study, as evidenced by the fact that both artery
and vein were responsive to the final KCl addition.
Studies have reported that many isoflavones and their
metabolites can reduce the vasoconstriction induced by KCl
in several different vessel types using rat models (28, 35). The
contractile response to KCl of endothelium-denuded rat aortic
rings was inhibited by pretreatment with genistein or daidzein
at both 3 × 10−5 and 1 × 10−4 M for 30 min (36). However, in
the same study, pretreatment with genistein or daidzein at
1 × 10−5 M did not relax the KCl-induced vasoconstriction. The
similar dose-dependent inhibition of F (1 × 10−5, 3 × 10−5, and
1 × 10−4 M) on the contractile response to KCl was observed in
rat mesenteric arteries without endothelium (37), where F again
failed to inhibit KCl-initiated contraction at 1 × 10−5 M. However,
in endothelium-intact rat aortic rings, Zhao et al. (38) reported
that pretreatment with 1 × 10−5, 3 × 10−5, and 5 × 10−5 M of F
all significantly inhibited the contractile response to KCl in a
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non-competitive manner. In the current study, the prior exposure
to F (1 × 10−6 M), biochanin A (1 × 10−6 M), and their combination did not have an impact on maximum contractile response
of mesenteric artery and vein to KCl in treatments either with or
without EXT. Since previous studies have indicated that the inhibition effects were dose-dependent (36, 37) and non-competitive
(38), it is possible that the isoflavone concentration (1 × 10−6 M)
in the current study was not high enough to elicit any inhibitory effects on the KCl response. However, in the current study,
maximum KCl responses were unaffected by F and B, which
validate the usage of KCl as a reference compound to normalize
the contractile responses.
There is limited information about isoflavones’ impact on
blood vessel morphology in regards to vessel inside and outside
diameters. In the current study, there was no significant evidence
of an F or B effect on mesenteric artery inside or outside diameter
regardless of EXT treatment. However, a tendency for a smaller
inside diameter induced by F treatment was observed in mesentery artery pretreated without EXT. One possible explanation for
this could be the inhibitory effect of F on vascular smooth muscle
cells. Previously, estrogens [tamoxifen (39), estradiol (40)] and
isoflavones [F and B (41)] have been shown to inhibit mitogeninduced proliferation, migration, and extracellular matrix
synthesis of smooth muscle cells. On the other hand, the inside
diameter of bovine lateral saphenous veins collected from steers
grazing high-endophyte tall fescue pasture were smaller than
those from steers grazing low-endophyte mixed-grass pasture
(16). Likewise, Egert et al. (15) observed a smaller outside diameter
of bovine mesenteric artery from endophyte-infected tall fescue
seed-dosed steers than control steers. One possible explanation
is the prolonged vasoconstriction induced by ergot alkaloids
results in decreased inside or outside diameter. Additionally, the
morphological changes of blood vessels, especially the expansion
of the tunica media smooth muscle layer, could also lead to a
smaller vessel insider diameter. It has been observed that calves
given ethanolic extracts of tall fescue hay had symptoms of fescue
foot and concomitant thickening of vessel walls and smaller vessel
lumens in blood vessels of the coronary bands and tail tips (42).
Similarly, Garner and Cornell (43) reported a thickening of the
smooth muscle layer of peripheral blood vessels after consumption
of endophyte-infected tall fescue. Although the exact mechanism
associated with thickening of smooth muscle layer is unclear,
evidence suggests hyperplasia over hypertrophy. Strickland et al.
(44) reported that ergonovine, ergovaline, and α-ergocryptine
stimulate the growth and mitosis of quiescent bovine vascular
smooth muscle cells in vitro. Although, in the present study, there
was no significant impact of F and B pretreatment on mesenteric
artery inside or outside diameters, the tendency of larger inside
diameter caused by F may indicate an alleviative effect on ergot
alkaloids induced thickening of vessel walls and smaller lumens.
In the current study for pretreatments without EXT, ERT
induced similar contractile response curves and −logEC50 values
(Control, F, B, and F+B) in mesenteric arteries. The shape of
contractile responses were similar with Egert et al. (15), who
reported ERT-induced contractile responses in mesenteric artery
from steers, not exposed to ergot alkaloids, with a −logEC50 value
of 6.03 ± 0.4 M. Whereas, the shape of mesenteric vein contractile
Frontiers in Nutrition | www.frontiersin.org

response curves were in contrast to the observations of Egert et al.
(15), which did not drop to negative values after reaching a maximum. Further, the maximum contractile response of mesenteric
vein to ERT in the current study was also lower (10% vs. 45% of
KCl maximum). The blood vessels used in the previous study (15)
did not undergo an in vitro pre-myograph incubation and utilized
blood vessels from steers compared to heifers in the current study.
Substantial evidence has shown that many ergot alkaloids are
vasoconstrictive in multiple types of vessels in various animal
models (7, 8). Among these vasoactive ergot alkaloids, ERT
and ergovaline were indicated as more potent vasoconstrictors
with lower EC50 values (relative to other alkaloids) in bovine
saphenous vein (45), ruminal vasculature (13), and mesenteric
vasculature (15). The current observation of the contractile
response induced by ERT was consistent with the previous findings in terms of vasoactivity for this alkaloid. Even though not
completely defined yet, numerous studies have been conducted to
investigate the mechanism of ergot alkaloid-caused vasoconstriction. The structural similarities of the ergoline ring system and
several biogenic amines [i.e., (nor)epinephrine, serotonin, and
dopamine] allows ergot alkaloids to interact with corresponding
biogenic amine receptors as ligands (30, 46). Substantial evidence
has shown that ergot alkaloids interact with dopamine-2 receptors (47, 48), α1-adrenergic receptors (49, 50), α2-adrenergic
receptors (51), and 5-HT2A receptors (14, 16, 17). The binding
with these G protein-coupled receptors activates the subunit of
the heterotrimeric G protein and then triggers various secondary
messaging systems and corresponding cytoplasmic signaling
transductions. The vasoconstrictive response induced by ERT
shown in the current study (Figure 2) could be explained by these
agonistic mechanisms.
The pre-myograph incubation with EXT altered the contractile
capacity of the mesenteric artery and vein. Using a bovine lateral
saphenous vein model, Klotz et al. (16) found that 2,5-dimethoxy4-iodoamphetamine (DOI), a 5-HT2A receptor agonist, induced
vessel contractile intensities were 35% lower in high endophyteinfested tall fescue than in low-endophyte-infested tall fescue,
whereas 5-carboxytryptamine (5-HT7 receptor agonist) produced
greater (37%) contractile intensities in high endophyte-infected
tall fescue. Taken together, this indicated that chronic exposure
to ergot alkaloids through grazing endophyte-infested tall fescue altered the vasoconstriction via serotonergic receptors. In
a subsequent study, Klotz et al. (17) reported a suppression of
the contractile response to ergovaline and 5-HT in steers grazing Kentucky-31 tall fescue infected with wild-type endophyte.
Further, Egert et al. (15) demonstrated a similar reduced contractile response to ERT in mesenteric vasculature of steers treated
with endophyte-infected tall fescue seed. Unsurprisingly, the
antagonistic effects of ergot alkaloids to certain 5-HT receptors
have been shown previously (49, 50, 52). Collectively, it is possible
that the EXT pretreatment in the present experiment reduced the
vasoconstriction to ERT via altering the biogenic amine receptor
activities.
Many in vitro bioassays have demonstrated that, in various vessel types and in numerous species, the binding of ergovaline and
receptor was irreversible, or the dissociation from the receptor was
very slow (14, 45, 50, 53). Likewise, an apparent bioaccumulation
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and B are metabolized to daidzein and genistein in the rumen
(59). As many metabolic studies have found, daidzein is further
metabolized by rumen and intestinal bacteria to equol, which has
a higher estrogenic potency than its isoflavone precursor (22, 23,
59). Equol undergoes renal clearance by clover-fed ruminants
(60, 61), which indicates that equol, rather than formononetin, is
present in the blood. It is possible that equol and other bacterial
metabolites of isoflavones could have greater effects on bovine
blood vessels. Thus, the different routes of administration of isoflavone treatments (in vivo vs. in vitro) may account some of the
inconsistencies, and the idea that bacterial or animal metabolism
might influence vasorelaxation is consistent with the aforementioned results by Sun et al. (58).
With EXT in the pretreatment media, F and B increased the
contractile response of mesenteric artery at several ERT concentrations. This has provided the first evidence that the isoflavones,
F and B, have potential to alleviate the vasoconstrictive effect of
ergot alkaloids. However, based on the current knowledge from
ergot alkaloids and isoflavones, there is little to mechanistically
explain this phenomenon, so more investigations on their
interactions are needed.

was reported in bovine lateral saphenous veins after repetitive
exposures of ergovaline in vitro (54). Additionally, studies have
indicated that ergot alkaloid-induced constriction is prolonged
and wash-resistant in human superficial temporal artery (55)
and coronary artery (56). These findings may explain the high
contractile response to the initial ERT addition (5 × 10−9 M) in
mesenteric arteries that were pretreated with EXT (1 × 10−6 M
ergovaline) in the current study. Furthermore, using an inositol
phosphate accumulation assay, Unett et al. (57) reported that
as a 5-HT2B agonist, ERT maintained similar potencies after
2 or 4-h extensive washout and this was due to internalization
or sequestration of the active ERT-bound receptor. It has been
demonstrated that ERT and ergovaline are equally potent vasoconstrictors inducing similar contractile responses (45). Thus,
these findings support the observations in the current study that
the elevated contractile response to very low concentrations of
ERT pretreated with EXT was numerically similar to 1 × 10−6 M
ERT-induced contractile response of mesenteric artery without
EXT incubation. This can be attributed to prior exposure to
ergovaline (in EXT) leading up to the myograph portion of the
experiment, and possible carry over of the vascular response to
ergovaline to the dose response to ERT.
In the present study, prior exposure to F and B failed to consistently alter the mesenteric vasculature contraction induced by
ERT. As discussed earlier in this section, numerous studies have
shown the vasodilative effect of isoflavones and their metabolites
in different vessel types. Pretreatment with F (3 × 10−5 and
5 × 10−5 M) antagonized contractile responses of rat thoracic
aortas to norepinephrine in a non-competitive manner (38). Sun
et al. (37) hypothesized that pre-incubation with F (3 × 10−5 and
1 × 10−4 M) depressed the contraction of rat mesenteric artery
to phenylephrine and 5-HT, and similarly, depression was not
observed when F at 1 × 10−5 M. The 1 × 10−6 M F and B concentrations in the present study were possibly not high enough to elicit
sufficient vasorelaxation to offset the ERT-induced vasoconstriction. Other evidence of the chronic antihypertensive effect of F
has been reported based on male spontaneously hypertensive rats
(SHR) (58). They found that the vasoconstriction of mesenteric
artery segments induced by phenylephrine or 5-HT was reduced
in F (50 mg/kg per day) orally administrated to SHR. The expression of α1-adrenoceptors and 5-HT2A/1B receptors in mesenteric
artery of F treated SHR decreased (58).
Even though there might be some species differences between
bovine and SHR, the 2-h pre-myograph incubation with F or B
in the present study may not be long enough to permit expression or induction of NOS by the tissues that were used. However,
sodium- and ATP-dependent K+ transport mechanisms, like
those described by Wu et al. (29), are very rapid. Further, F

CONCLUSION
In conclusion, this study indicated that a pre-myograph incubation with F, B at 1 × 10−6 M and their combination did not affect
the contractile response to ERT in mesenteric vasculature. The
pre-myograph incubation of mesenteric vasculature with EXT
(equivalent to 1 × 10−6 M ergovaline) reduced the vasoactivity of
ERT, and there were some indications that F and B may alleviate
this reduction. At higher concentrations, F and B may alleviate
this reduction in vasoactivity caused by prior exposure to ergot
alkaloids. Future studies with higher isoflavone dosages or longer
exposure may be helpful to further investigate the ergot alkaloids
and isoflavones interaction. Additionally, this study was confined
to the mesenteric veins and arteries. It is plausible that effects
could be elicited in other vessels with different expression levels of
5-HT, NOS, or other factors. In vivo research, which takes isoflavone metabolism into account, is necessary to better understand
the interaction from a practical perspective.
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